Overexpression of FTO Protects Human Granulosa Cells From Cisplatin-Induced Injury

Rongli Wang,Xinyuan Yang
DOI: https://doi.org/10.21203/rs.3.rs-929583/v1
2021-01-01
Abstract:Abstract Background: Premature ovarian failure (POF) is a serious problem for young women who received chemotherapy, and its pathophysiological basis is the dysfunction of granulosa cells. The RNA methylation on the sixth Natom of adenylate (m6A) plays an important role in epigenetic regulation, and previous studies have demonstrated that the fat mass- and obesity-associated (FTO) was decreased in POF and may be a biomarker for the occurrence of POF. Furthermore, to preserve the fertility of these young females, various approaches have been used to prevent chemotherapy-induced ovarian failure, and menstrual-derived stem cells (MenSCs) have been considered as a promising treatment strategy. Here, we aimed to explore the role of FTO in the MenSCs recovering the function of injured granulosa cells.Method: First, the cisplatin was used to make a granulosa cell injury model. Then, the menstrual-derived stem cells (MenSCs)-injured granulosa cells co-culture model and POF mouse model were established in this study to explore the role of FTO. Human ovarian granulosa cell lines (KGN) were used to explore the effect of FTO on cell proliferation and apoptosis. Furthermore, gain- and loss-of-function studies, small interfering RNA transfection, and meclofenamic acid (MA), a highly selective inhibitor of FTO, were also conducted to clarified the regulation mechanism of FTO in granulosa.Results: MenSCs co-culture could improve the function of injured granulosa cells by increasing the expression of FTO. MenSCs transplantation could restore the expression of FTO in the ovary of POF mice. Overexpression of FTO could restore the injured cells’ proliferation and decrease its apoptosis through regulating the expression of BNIP3. Down-regulation of FTO got the opposite results.Conclusion: FTO has a protective effect, which could improve the viability of granulosa cells after cisplatin treatment by decreasing the expression of BNIP3, and it may provide new insight into the therapeutic targets for the cisplatin-induced POF.
What problem does this paper attempt to address?